SavedAdd your journal

Journals / Türk Onkoloji Dergisi / 2009 / Cilt: 24 - Sayı: 2

The importance of pretreatment performance status and LDH level in patients with stage III-IV nasopharyngeal carcinoma

Evre III-IV nazofarinks kanseri tanılı hastalarda tedavi öncesi performans durumu ve LDH düzeyinin önemi

Hakan KARAGÖL
Murat ÇALOĞLU
Vuslat YÜRÜT-ÇALOĞLU
Ruşen COŞAR-ALAS
Zafer KOÇAK
Pages
65–72
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Gender (p=0.022), Eastern Cooperative Oncology Group (ECOG) performance status (PS) (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES To evaluate the prognostic factors in patients treated with radiotherapy for locally advanced nasopharyngeal carcinoma.METHODS Forty-eight patients (37 males, 11 females) treated between September 1999 and September 2007 were assessed retrospectively.RESULTS Ten patients (21%) recurred loco-regionally.
📊
Key Findings & Data:OBJECTIVES To evaluate the prognostic factors in patients treated with radiotherapy for locally advanced nasopharyngeal carcinoma.METHODS Forty-eight patients (37 males, 11 females) treated between September 1999 and September 2007 were assessed retrospectively.RESULTS Ten patients (21%) recurred loco-regionally.
💡
Conclusion & Impact:Gender (p=0.022), Eastern Cooperative Oncology Group (ECOG) performance status (PS) (p
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVES To evaluate the prognostic factors in patients treated with radiotherapy for locally advanced nasopharyngeal carcinoma.METHODS Forty-eight patients (37 males, 11 females) treated between September 1999 and September 2007 were assessed retrospectively.RESULTS Ten patients (21%) recurred loco-regionally. Gender (p=0.022), Eastern Cooperative Oncology Group (ECOG) performance status (PS) (p

Özet

AMAÇ Radyoterapi ile tedavi edilen evre III-IV nazofarinks kanserli hastalarda prognostik faktörler incelendi.GEREÇ VE YÖNTEM Eylül 1999-Eylül 2007 tarihleri arasında tedavi edilen 48 hasta (37 erkek, 11 kadın) geriye dönük olarak değerlendirildi.BULGULAR Lokal-bölgesel yineleme 10 (%21) hastada izlendi. Lokal-bölgesel kontrolü etkileyen faktörler; cinsiyet (p=0.022), Eastern Cooperative Oncology Group (ECOG) performans durumu (p

🔖

Cite This Article

KARAGÖL, H., ÇALOĞLU, M., YÜRÜT-ÇALOĞLU, V., COŞAR-ALAS, R., KOÇAK, Z. (2022). The importance of pretreatment performance status and LDH level in patients with stage III-IV nasopharyngeal carcinoma. Türk Onkoloji Dergisi, Cilt: 24 - Sayı: 2, 65–72. https://ajindex.com/articles/639321

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Chan AT, Teo PM, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol 2002;13(7):1007-15
  2. Teo PM, Kwan WH, Lee WY, Leung SF, Johnson PJ. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 1996;77(12):2423-31. 3) al-Sarraf M, Pajak TF, Cooper JS, Mohiuddin M, Herskovic A, Ager PJ. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study. J Clin Oncol 1990;8(8):1342-51
  3. Cheng SH, Tsai SY, Horng CF, Yen KL, Jian JJ, Chan KY, et al. A prognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006;66(4):992-1003
  4. Turen S, Ozyar E, Altundag K, Gullu I, Atahan IL. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Cancer Invest 2007;25(5):315-21
  5. Dimery IW, Peters LJ, Goepfert H, Morrison WH, Byers RM, Guillory C, et al. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol 1993;11(10):1919-28
  6. Garden AS, Lippman SM, Morrison WH, Glisson BS, Ang KK, Geara F, et al. Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography. Int J Radiat Oncol Biol Phys 1996;36(5):1005-12
  7. Geara FB, Glisson BS, Sanguineti G, Tucker SL, Garden AS, Ang KK, et al. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study. Cancer 1997;79(7):1279-86
  8. Ma J, Mai HQ, Hong MH, Min HQ, Mao ZD, Cui NJ, et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 2001;19(5):1350-7
  9. Liaw CC, Wang CH, Huang JS, Kiu MC, Chen JS, Chang HK. Serum lactate dehydrogenase level in patients with nasopharyngeal carcinoma. Acta Oncol 1997;36(2):159-64
  10. Kolev Y, Uetake H, Takagi Y, Sugihara K. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol 2008;15(8):2336-44
  11. Swan F Jr, Velasquez WS, Tucker S, Redman JR, Rodriguez MA, McLaughlin P, et a